Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the period ending April 30, 2024. The document serves as a notice regarding the company's 2024 Annual General Meeting of Shareholders, scheduled for June 6, 2024, at the company's offices in Rehovot, Israel. The record date for shareholders entitled to vote is May 3, 2024.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing concerning corporate governance and shareholder meetings rather than a financial results report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this document, as it contains no financial data.
Guidance, Outlook, and Corporate Governance
The filing details the agenda for the Annual General Meeting, including proposals to be voted upon. It incorporates by reference the Notice of Meeting (Exhibit 99.1), the Proxy Statement (Exhibit 99.2), and the Proxy Card (Exhibit 99.3). These exhibits contain background information on proposals, voting procedures, and details regarding the board of directors and corporate governance. The filing also notes that these contents are incorporated into the company's registration statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- Meeting Date: June 6, 2024, at 3:00 p.m. Israel time.
- Record Date: Shareholders of record as of May 3, 2024, are eligible to vote.
- Location: 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel.
- Exhibits: Review Exhibits 99.1, 99.2, and 99.3 for specific proposal details and voting instructions.
- Financial Data: This filing does not contain financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.